Form 4: Amgen EVP Esteban Santos Reports Stock Disposition

Amgen Inc. EVP of Operations Esteban Santos reported the disposition of 522 shares of common stock to cover tax obligations.

Summary

• Esteban Santos, EVP of Operations at Amgen Inc., disposed of 522 shares of common stock on May 7, 2026.
• The shares were disposed of at a price of $331.11 per share.
• The transaction was executed to satisfy tax withholding obligations related to the vesting of equity awards.
• Following this transaction, the reporting person maintains direct beneficial ownership of 82,847 shares.
• The reporting person also holds 909.9906 shares indirectly through a 401(k) plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is purely administrative and related to tax obligations rather than a market-driven divestment.

Positives

• The transaction is a routine administrative action related to tax withholding rather than a discretionary sale of shares.

Negatives

• The transaction results in a minor reduction of the executive's direct equity stake in the company.

Risks

• None identified; this is a standard regulatory filing for executive compensation tax compliance.

Future Outlook

No forward-looking guidance or strategic outlook provided in this filing.

Industry Context

StockSavvy.ai notes that routine tax-related share dispositions by high-level executives are standard practice in the biotechnology sector and do not typically signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction aligns with standard executive compensation practices observed at large-cap pharmaceutical companies like Pfizer, Merck, and Gilead Sciences.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a standard tax-related equity adjustment.

Key Dates

Keywords

Amgen, AMGN, Form 4, Insider Trading, Executive Compensation, Stock Disposition